Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.7.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
 12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Revenues, net:    
Product $ 7,796,319 $ 7,242,503
Recurring 459,695 285,114
Total Net Revenue 8,256,014 7,527,617
Cost of Sales:    
Product 4,024,675 3,600,407
Recurring 124,842 151,958
Total Cost of Sales 4,149,517 3,752,365
Gross Profit 4,106,497 3,775,252
Operating Expenses:    
Research and development 1,658,640 1,605,667
Selling, general and administrative 6,336,879 5,123,027
Depreciation and amortization 34,289 29,223
Total Operating Expense 8,029,808 6,757,917
Operating Loss (3,923,311) (2,982,665)
Other (Expenses) Income:    
Interest (expense) income, net (60,246) (69,441)
Total Other (Expenses) (60,246) (69,441)
Loss from Continuing Operations before Provision (Benefit) for Income Taxes (3,983,557) (3,052,106)
Provision (Benefit) for Income Taxes 20,114 (3,214)
Net loss from continuing operations (4,003,671) (3,048,892)
Discontinued Operations:    
Income from Discontinued Operations (Net of Tax) 2,627,758 2,859,788
Net Loss (1,375,913) (189,104)
Accretion of preferred dividends and discount 0 (18,253)
Net loss attributable to common stockholders $ (1,375,913) $ (207,357)
Net income (loss) per common share:    
Basic - continuing operations $ (0.03) $ (0.02)
Basic - discontinued operations 0.02 0.02
Basic - net loss attributable to common stockholders (0.01) (0.00)
Diluted - continuing operations (0.03) (0.02)
Diluted - discontinued operations 0.02 0.02
Diluted - net loss attributable to common stockholders $ (0.01) $ (0.00)
Weighted Average Common Shares Outstanding - basic 132,774,475 125,859,903
Weighted Average Common Shares Outstanding - diluted 132,774,475 125,859,903